Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.
The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.
Proteon Therapeuticsâ€™ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures.
The companyâ€™s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).
Past Team (3)Update
Funding Rounds (5) - $126.5MUpdate
Board Members and Advisors (2)Update
Bessemer Venture Partners has over 100 years of investing experience, with a portfolio ranging...
Life Sciences Venture Firm
Healthcare Venture Capital
Intersouth Partners is one of the most active and experienced venture funds in the Southeast,...
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in...
TVM Capital is a global venture and growth capital firm with a 25 year operating track record.
Pharmstandard is a pharmaceutical company that develops and manufactures modern pharmaceutical...
200 West Street
Waltham, MA 02451